Literature DB >> 6969575

Effect of clavulanic acid on minimal inhibitory concentrations of 16 antimicrobial agents tested against Legionella pneumophila.

D J Pohlod, L D Saravolatz, E L Quinn, M M Somerville.   

Abstract

A total of 15 Legionella pneumophilia isolated were tested against 16 antimicrobial agents used singly and in combination with clavulanic acid. When combined with clavulanic acid, 4 of the 16 antimicrobial agents produced no enhanced effect. However, the minimal inhibitory concentrations of 12 of the antimicrobial agents were reduced by one-half to one-third when in combination with clavulanic acid. These reductions reflected only a one-dilution decrease, however, in the original minimal inhibitory concentrations. Thus, clavulanic acid combinations appear to be only nominally effective beta-lactamase inhibitors against L. pneumophilia.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6969575      PMCID: PMC283995          DOI: 10.1128/AAC.18.2.353

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

1.  Inhibition of beta-lactamase in Neisseria gonorrhoeae by sodium clavulanate.

Authors:  J M Miller; C N Baker; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

2.  Inactivation of beta-lactam antibiotics by Legionella pneumophila.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

3.  Clavulanic acid, a novel inhibitor of beta-lactamases.

Authors:  H C Neu; K P Fu
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

4.  Legionnaires' disease: description of an epidemic of pneumonia.

Authors:  D W Fraser; T R Tsai; W Orenstein; W E Parkin; H J Beecham; R G Sharrar; J Harris; G F Mallison; S M Martin; J E McDade; C C Shepard; P S Brachman
Journal:  N Engl J Med       Date:  1977-12-01       Impact factor: 91.245

5.  Effect of clavulanic acid on the in vitro synergism between carbenicillin and gentamicin against Serratia marcescens.

Authors:  T Sirisanthana; S A Lerner
Journal:  Antimicrob Agents Chemother       Date:  1979-04       Impact factor: 5.191

  5 in total
  6 in total

1.  Bactericidal effects of ticarcillin-clavulanic acid against Legionella pneumophila pneumonia in immunocompromised weanling rats.

Authors:  G M Smith; K H Abbott; M J Wilkinson; A S Beale; R Sutherland
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

Review 2.  Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use.

Authors:  R N Brogden; A Carmine; R C Heel; P A Morley; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-11       Impact factor: 9.546

3.  In vitro extracellular and intracellular activities of clavulanic acid and those of piperacillin and ceftriaxone alone and in combination with tazobactam against clinical isolates of Legionella species.

Authors:  P H Edelstein; M A Edelstein
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

4.  Comparative activities of piperacillin and tazobactam against clinical isolates of Legionella spp.

Authors:  L A Collins; C B Wennersten; M J Ferraro; R C Moellering; G M Eliopoulos
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

5.  Susceptibility of Legionella spp. to imipenem and 27 other beta-lactam antibiotics.

Authors:  G Ruckdeschel; W Ehret; A Ahl
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

Review 6.  Piperacillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  B Holmes; D M Richards; R N Brogden; R C Heel
Journal:  Drugs       Date:  1984-11       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.